Medical research

ATCC Appoints Dr. Alfredo Molinolo to Its Board of Directors

Retrieved on: 
Thursday, November 2, 2023
Science, Stem Cells, Biotechnology, Research, Oncology, Health, Infectious Diseases, Genetics, Moores Cancer Center, Biorepository, DVM, Faculty of Medical Sciences, University of Buenos Aires, Head, Publication, Doctor of Philosophy, National Institute of Dental and Craniofacial Research, Hospital Rivadavia, HNSCC, Mouse Models of Human Cancer database, Medicine, Breast cancer, Medical research, University, University of California, San Diego, Collection, Breast, Bangladesh Technical Education Board, Neck, Management, Pathology, ATCC, MD, Biology, Cancer

“Alfredo’s scientific expertise in pathology, oncology and histotechnology will be a great resource for our company,” said ATCC Chairman and CEO Raymond H. Cypess , DVM, PhD.

Key Points: 
  • “Alfredo’s scientific expertise in pathology, oncology and histotechnology will be a great resource for our company,” said ATCC Chairman and CEO Raymond H. Cypess , DVM, PhD.
  • Dr. Molinolo earned both his PhD in oncology and MD in medicine from the University of Buenos Aires in Argentina.
  • Dr. Molinolo has received several awards and has written numerous publications about breast, oral, and head and neck cancer.
  • “Serving on the Board is an opportunity for me to make further contributions to science,” said Dr. Molinolo.

Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize

Retrieved on: 
Thursday, November 2, 2023
Science, Health, Neurology, Research, Sequence, Feinstein Institutes for Medical Research, Inflammation, Karolinska Institute, Doctor of Philosophy, Rheumatoid arthritis, Biomedical sciences, Shock, Immunity, Neuroscience, Boston University, Neurosurgery, Death, Rockefeller University, Medical research, Hope, Nobel Committee, Vagus nerve stimulation, Reflex, Cytokine, Boston College, Royal Academies for Science and the Arts of Belgium, Northwell Health, Medicine, Credit, UNESCO Science Prize, Patient, Vagus nerve, Septic shock, Human, University Medical Center, BS, Laboratory, Travel, Olivia Wigzell, Chemistry, Survival, Education, Royal Academy of Arts, Water, Multimedia, Dana, Engineering, Rockefeller, Student, Dana Foundation, Sepsis, Inflammatory bowel disease, Nursing, Pharmaceutical industry, Medical device, MD

The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Key Points: 
  • The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
  • Dr. Tracey will travel to Stockholm, Sweden, to receive the prize, which includes $100,000, and deliver a lecture on December 1.
  • View the full release here: https://www.businesswire.com/news/home/20231102553265/en/
    Dr. Kevin J. Tracey has been named awardee of the 2023 Hans Wigzell Research Foundation's Science Prize.
  • “The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases,” said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Dimensional Innovations Integrates Immersive Storytelling Experiences into American Century Investments' Global Headquarters

Retrieved on: 
Monday, November 6, 2023
Asset, Element, Medical research, American Century Investments, Smartphone, Optimism, Stowers Institute for Medical Research, Stowers, System, Health, Augmented reality, History, Research, Investment, Century, Environment, Trust, American Century, Culture, Video game, Entertainment

KANSAS CITY, Mo., Nov. 6, 2023 /PRNewswire/ -- Dimensional Innovations (DI) is proud to announce its collaboration with American Century Investments to integrate immersive storytelling elements into the $210 billion* investment firm's global corporate headquarters. Augmented reality, generative art, sculptural design, and built components create a tech-forward environment where American Century's employees, clients and visitors can explore the investment firm's compelling 65-year history through more than 25 touch points throughout the lobby scanned via smartphone application.

Key Points: 
  • KANSAS CITY, Mo., Nov. 6, 2023 /PRNewswire/ -- Dimensional Innovations (DI) is proud to announce its collaboration with American Century Investments to integrate immersive storytelling elements into the $210 billion* investment firm's global corporate headquarters.
  • Upon entering, guests and employees are greeted by the American Century Investments Cultivation Wall — a 15-foot-tall, multi-dimensional, kinetic LED display commemorating employees, and highlighting custom messages to engage the community at large.
  • "American Century Investments is a bedrock of the global financial world, so we were thrilled to help establish a remarkable and interactive touchpoint that tells their story to anyone who visits their Kansas City headquarters," said Tucker Trotter, CEO, Dimensional Innovations.
  • To learn more about the project and each element, visit Dimensional Innovations' website/project page.

Recognizing and Celebrating Outstanding Contributions to the Canadian Cancer Research Community

Retrieved on: 
Monday, November 6, 2023
Women of Outstanding Achievement Photographic Exhibition, FRSC, ISCB Senior Scientist Award, Order of Ontario, FCAN, Medical research, Myeloma Canada, Molecular biology, Multiple myeloma, FRS, Genetics, Jewish General Hospital, Psycho-oncology, RN, Conference, Organization, Federation, Doctor of Philosophy, FRCPC, Doctor of Science, University of Hong Kong, Research, Toronto Metropolitan University, Patient, Senior, McGill University, Princess Margaret Cancer Centre, Professor, University of Toronto, Immune system, Canadian Partnership Against Cancer, University, OC, FCAHS, Palliative care, Distinguished Service to Music Medal, CCRA, Toronto, Breast cancer, University Health Network, University of Manitoba, Ovarian Cancer Research Alliance, Pharmaceutical industry, Nursing, Management, MD, Pharmacology, Cancer

TORONTO, Nov. 6, 2023 /CNW/ - Today, the Canadian Cancer Research Alliance (CCRA) announces the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.

Key Points: 
  • TORONTO, Nov. 6, 2023 /CNW/ - Today, the Canadian Cancer Research Alliance (CCRA) announces the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.
  • Awardees will be honoured at the Canadian Cancer Research Conference, which is taking place in Halifax from November 12 to 14.
  • Initiated in 2011, the CCRA Awards acknowledge and celebrate the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community, as well as those who have shown exceptional leadership in patient involvement in cancer research.
  • The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to better ways to prevent, diagnose, and treat cancer, and improve patient and survivor outcomes.

Global Protein Labeling Market Size, Share & Trends Analysis Report 2023-2030 - Innovative Techniques Propel Global Protein Labeling Market Forward - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023
Biotechnology, Science, Health, Research, Molecular biology, Biomarker, Copenhagen, Cell biology, Reagent, PTM, Investment, Cell, Mass spectrometry, Novo Nordisk Foundation Center for Protein Research, Medical research, University of Copenhagen Faculty of Health and Medical Sciences, Growth, Genomics, Immune system, A-DNA, Neuroscience, Biochemistry, University, USD, Mass, Novo Nordisk Foundation, Proteomics, Biomedicine, Assay, Medical imaging, Vaccine, Pharmaceutical industry

Protein labeling is undergoing a significant transformation, driven by the burgeoning interest in Post-translational Modification (PTM) studies.

Key Points: 
  • Protein labeling is undergoing a significant transformation, driven by the burgeoning interest in Post-translational Modification (PTM) studies.
  • The application of advanced quantification methods, such as iodoTMTzero Label Reagent, is facilitating the efficient detection of PTMs, propelling the market forward.
  • Biomedical research is at the forefront of driving growth in the global protein labeling market.
  • The surge in PTM studies, fueled by breakthroughs in protein expression quantification and innovative tagging strategies, is a pivotal factor.

Dr. Kevin J. Tracey receives Hans Wigzell Research Foundation's Science Prize amounting to USD 100.000

Retrieved on: 
Thursday, November 2, 2023
Medical research, Feinstein Institutes for Medical Research, Vagus nerve stimulation, Inflammation, Doctor of Philosophy, Rheumatoid arthritis, Research, Northwell Health, Neuroscience, Value Partners (asset management), USD, Patient, Inflammatory bowel disease, Pharmaceutical industry, MD

STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.

Key Points: 
  • STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.
  • Dr. Tracey receives the prize of USD 100.000 for his contributions to the fields of neuroscience and neuroimmunology and his pioneering discoveries in vagus nerve stimulation, the inflammatory reflex and bioelectronic medicine.
  • Dr. Tracey's discovery of the body's "inflammatory reflex" – a neural circuit regulating inflammatory responses, is on of his most important achievements.
  • "The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases," said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Global Virus Network’s Top Virologists Partner with Monaco to Advance Pandemic Preparedness Across EU Countries

Retrieved on: 
Friday, October 20, 2023
Global Virus Network, Big data, Artificial intelligence, Disease, Risk, Partnership, Public, AI, Citizen science, Hospital, Infection, Swiss Federal Institute of Technology, Medical research, SARS-CoV-2, Vaccine, HIV, CSM, University, United States National Library of Medicine, WHO, Duke–NUS Medical School, Data collection, Research, Prince, Politics, COVID, World Health Organization, Travel, Privacy, Rega Institute for Medical Research, European Bioinformatics Institute, Climate change, National library, Swiss Federal Institute of Aquatic Science and Technology, GVN, Virus, Genomics, Casino, Pharmaceutical industry, Medical device

Prince Albert II of Monaco, among other dignitaries including from the World Health Organization (WHO) and the GVN.

Key Points: 
  • Prince Albert II of Monaco, among other dignitaries including from the World Health Organization (WHO) and the GVN.
  • Prince Albert II of Monaco said, “I am delighted to support and attend this symposium to improve pandemic preparedness here in Monaco and abroad.
  • We have a duty to remain vigilant, strengthen global governance, and strengthen infrastructure and healthcare systems.
  • Studies showed that phone apps tracking COVID cases and notifying those with exposure, significantly impacted hospitalization and death rates.

3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic

Retrieved on: 
Wednesday, October 25, 2023
Knowledge, CAR, PD-L1, UCSF, CSO, IND, Autoimmunity, Therapy, Culture, TCR, Lightspeed Venture Partners, Investigational New Drug, University of California, CTA, Acquisition, Immunity, Research, Journal of Experimental Medicine, Harvard University, Inflammation, Multimedia, R, Journal, Cancer immunology, Cell, Nature Communications, Immune system, Amgen, Drug discovery, Cancer, Microbiology, Canadian Aviation Regulations, Medical research, Immunotherapy, University, Roche, Sanofi, Genentech, Safety, Patient, Doctor of Philosophy, Coronavirus Scientific Advisory Board, Management, Vaccine, Pharmaceutical industry, Science

SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 /PRNewswire/ -- 3T Biosciences ("3T"), an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, today announced the appointment of Bryan Irving, Ph.D., as chief scientific officer (CSO). In this role, Dr. Irving will be responsible for the company's scientific strategy and direction and will chair 3T's Scientific Advisory Board.

Key Points: 
  • In this role, Dr. Irving will be responsible for the company's scientific strategy and direction and will chair 3T's Scientific Advisory Board.
  • His work has focused primarily on exploring ways to modulate T-cell activity for therapeutic benefit in both oncology and autoimmune settings.
  • "3T shares my passion for innovation and has a culture of rigor and dedication to advancing novel therapies.
  • 3T Biosciences is an immunotherapy company focused on discovering and developing next-generation therapies with curative potential based on its immune-response-guided target discovery approach.

Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub

Retrieved on: 
Thursday, October 19, 2023
Mental Health, Health, Biometrics, Clinical Trials, Research, Science, Biotechnology, Knowledge, Patient, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical research, Feinstein, Feinstein Institutes for Medical Research, Transcranial magnetic stimulation, Johns Hopkins University, Zucker Hillside Hospital, Hofstra University, Psychiatry, Bipolar disorder, Multimedia, Donald, Clinical trial, Schizophrenia, Institutional review board, Behavioural sciences, Credit, University, Magnetic resonance imaging, University of California, Los Angeles, BD2, University of Michigan, Hospital, BSN, Mayo Clinic, Pharmaceutical industry, MD, Brigham, Wellcome

Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.

Key Points: 
  • Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
  • Through a national research grant and innovative networking system aimed to connect patients to care, it might become easier for people with bipolar disorder to find new treatments and clinical trials.
  • (Credit: Feinstein Institutes)
    Researchers at The Feinstein Institutes for Medical Research received a $6.1 million grant from Breakthrough Discoveries for Thriving with Bipolar Disorders Foundation (BD2) to serve as a hub of six other sites across the country.
  • “Although bipolar disorder impacts millions of Americans every year, it is under-researched,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

Vagus nerve stimulation reduces inflammation in children with Inflammatory Bowel Disease, Feinstein Institutes study finds

Retrieved on: 
Wednesday, October 18, 2023
Research, Managed Care, General Health, Consumer, Medical Devices, Children, Science, Biotechnology, Neurology, Practice Management, Other Science, Health, Abdominal pain, Child, MRI, Medical research, Feinstein, Inflammation, Feinstein Institutes for Medical Research, Cohen, FC, Vagus nerve, Weatherall Institute of Molecular Medicine, Heart rate, Diarrhea, Human, Medicine, Prevalence, Vagus nerve stimulation, Incontinence, Diabetes, Rheumatoid arthritis, MBA, Electricity, TENS, Bleeding, GE Research, Ulcerative colitis, Multimedia, Northwell Health, Disease, Clinical trial, Nature Communications, Pulmonary hypertension, Neuroscience, Ear, Arthritis, IBD, Sickle Cell Anemia, a Molecular Disease, Credit, Molecular medicine, Brain, Cancer, Patient, Liver disease, Biomedical engineering, Bangladesh Technical Education Board, MS, Central nervous system, Lupus, Medical imaging, Pharmaceutical industry, Management, Gastroenterology, MD

View the full release here: https://www.businesswire.com/news/home/20231018401966/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231018401966/en/
    The Feinstein Institutes for Medical Research’s Dr. Benjamin Sahn led the vagus nerve stimulation clinical trial.
  • Inflammation and the inflammatory reflex – the neuronal signaling between the brain and body – is an important immune response.
  • Previous research and functional MRI studies have mapped stimulation of the auricular branch of the vagus nerve to activate the same brain regions as implanted devices, confirming this nerve as a suitable non-invasive target to administer vagus nerve stimulation.
  • Also, Feinstein Institutes researchers, in collaboration with GE Research, published research that harnessed ultrasound technology to reduce inflammation in the body non-invasively.